Compounding Pharmacy Market Share, Overview, Competitive Analysis and Forecast 2031

Comments ยท 6 Views

The Compounding Pharmacy Market in 2023 is US$ 9.16 billion, and is expected to reach US$ 14.85 billion by 2031 at a CAGR of 6.2%.

The Compounding Pharmacy Market in 2023 is US$ 9.16 billion, and is expected to reach US$ 14.85 billion by 2031 at a CAGR of 6.2%.

 

FutureWise Research published a report that analyzes Compounding Pharmacy Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Compounding Pharmacy research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Compounding Pharmacy Market Sample

 

Compounding Pharmacy Market Segmentation:

By Therapeutic Area

·        Hormone Replacement

·        Pain Management

·        Dermatology applications

·        Specialty drugs

·        Nutritional supplements

·        Others

By Product

·        Oral

·           Solid preparations

·                Tablets

·                Capsules

·               Granules

·                Powder

·                Others

·           Liquid preparations

·                Solutions

·                Suspension

·                Emulsion

·                Syrup

·                Others

·        Topical

·           Ointments

·           Creams

·           Gels

·           Pastes

·           Others

·        Rectal

·           Suppositories

·           Enema

·           Others

·        Parenteral

·           LVP

·           SVP

·        Nasal

·        Ophthalmic

·        Otic

By Application

·        Children

·        Adult

·        Geriatric

·        Veterinary

 By Compounding Type

·        Pharmaceutical Ingredient Alteration (PIA)

·        Currently Unavailable Pharmaceutical Manufacturing (CUPM)

·        Pharmaceutical Dosage Alteration (PDA)

·        Others

By Sterility

·        Sterile dosage form

·        Non-sterile dosage forms

By Distribution Channels

·        Hospital pharmacy

·        Compounding pharmacies

·        Others

By Region

·        North America

·        Europe

·        Asia-Pacific

·        Latin America

·        Middle East and Africa

Major players included in the Compounding Pharmacy Market:

·        B. Braun Medical

·        Dougherty's Pharmacy

·        Fagron

·        Fresenius Kabi

·        Institutional Pharmacy Solutions

·        Clinigen Group PLC

Comments